Suppr超能文献

[体内复律在永久性心房颤动治疗中的作用。关于28例的早期结果]

[Role of internal cardioversion in the treatment of permanent atrial fibrillation. Early results apropos of 28 cases].

作者信息

Chauvin M, Koenig A, Theolade R, Brechenmacher C

机构信息

Service de cardiologie, CMCO, Schiltigheim.

出版信息

Arch Mal Coeur Vaiss. 1991 Mar;84(3):377-82.

PMID:2048924
Abstract

Internal cardioversion is a new method of treating atrial fibrillation. It consists in delivering an electric shock between an electrode positioned in the right atrium and a dorsal electrode. A quadripolar electrophysiological catheter is used as the proximal electrode, the two distal poles of which are used to locate the His bundle deflection. Care is taken that the electrode used for cardioversion is not in contact with the atrial wall by using biplane fluoroscopy and unipolar endocavitary recordings. Twenty-eight patients (18 men and 10 women) average age 55 years, underwent this treatment for chronic atrial fibrillation resistant to one or two attempts at external cardioversion. Each patient was given one or two shocks (average 1.68) in the same session. There were 22 immediate reversions to sinus rhythm, giving a primary success rate of 78.57%. Four patients relapsed in the 3 days following the procedure, giving a short term success rate of 64.28%. The minimum effective energy would seem to be 200 joules. The only rhythm complications were sinus bradycardia and/or atrioventricular block lasting a few seconds, both countered by prophylactic ventricular pacing : no traumatic complications due to electric shock were observed. The long term results show sinus rhythm maintained in 66.66% of patients at 6 months and more. In conclusion, internal cardioversion is an effective method of treating cardiac arrhythmias resistant to external cardioversion. The procedure would seem to be reliable and relatively atraumatic. The long term results are promising, particularly the stability of sinus rhythm which seems to be longer than after external cardioversion, by they need further confirmation.

摘要

体内心脏复律是一种治疗心房颤动的新方法。它是通过位于右心房的电极与背部电极之间施加电击来实现的。使用四极电生理导管作为近端电极,其两个远端电极用于定位希氏束波。通过使用双平面荧光透视和单极心腔内记录,确保用于心脏复律的电极不与心房壁接触。28例患者(18例男性和10例女性),平均年龄55岁,因慢性心房颤动经一或两次体外心脏复律尝试无效而接受此治疗。每位患者在同一次治疗中接受一或两次电击(平均1.68次)。有22例立即恢复窦性心律,一次成功率为78.57%。4例患者在术后3天复发,短期成功率为64.28%。最低有效能量似乎为200焦耳。唯一的节律并发症是窦性心动过缓和/或房室传导阻滞持续数秒,两者均通过预防性心室起搏得以纠正:未观察到因电击引起的创伤性并发症。长期结果显示,6个月及以上患者中66.66%维持窦性心律。总之,体内心脏复律是治疗对体外心脏复律耐药的心律失常的有效方法。该操作似乎可靠且相对无创。长期结果令人鼓舞,尤其是窦性心律的稳定性似乎比体外心脏复律后更长,但仍需进一步证实。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验